Similar articles for PMID: 26957621

Year	Number of Results
1993	1
1998	2
2001	1
2003	2
2004	1
2005	3
2006	4
2007	2
2008	2
2009	2
2010	4
2011	3
2012	3
2013	7
2014	8
2015	9
2016	6
2017	7
2018	4
2019	4
2024	0

1

Re: "Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course".

Klauschen F, Bläker H, Stenzinger A, Chapman JS, Collisson EA, Taylor BS. Klauschen F, et al. J Natl Compr Canc Netw. 2016 Mar;14(3):lxvi-lxviii. doi: 10.6004/jnccn.2016.0040. J Natl Compr Canc Netw. 2016. PMID: 26957621 No abstract available.

2

Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course.

Chapman JS, Asthana S, Cade L, Chang MT, Wang Z, Zaloudek CJ, Ueda S, Collisson EA, Taylor BS. Chapman JS, et al. J Natl Compr Canc Netw. 2015 Jul;13(7):835-45. doi: 10.6004/jnccn.2015.0101. J Natl Compr Canc Netw. 2015. PMID: 26150578

3

The Authors Respond.

Chapman JS, Collisson EA, Taylor BS. Chapman JS, et al. J Natl Compr Canc Netw. 2016 Mar;14(3):lxviii. J Natl Compr Canc Netw. 2016. PMID: 27396027 No abstract available.

4

[Clinical significance and distribution of BRCA genes mutation in sporadic high grade serous ovarian cancer].

Liu WL, Wang ZZ, Zhao JZ, Hou YY, Wu XX, Li W, Dong B, Tong TT, Guo YJ. Liu WL, et al. Zhonghua Fu Chan Ke Za Zhi. 2017 Jan 25;52(1):26-31. doi: 10.3760/cma.j.issn.0529-567X.2017.01.007. Zhonghua Fu Chan Ke Za Zhi. 2017. PMID: 28190312 Chinese.

5

[Pathologic features of BRCA-associated ovarian carcinoma].

Guo DH, Zheng WX. Guo DH, et al. Zhonghua Bing Li Xue Za Zhi. 2013 Dec;42(12):846-50. Zhonghua Bing Li Xue Za Zhi. 2013. PMID: 24507111 Chinese. No abstract available.

6

Genetic testing in ovarian cancer: getting better, and maybe not just for disease susceptibility anymore.

Berchuck A. Berchuck A. Obstet Gynecol. 2012 Aug;120(2 Pt 1):221-2. doi: 10.1097/AOG.0b013e3182602599. Obstet Gynecol. 2012. PMID: 22825078 No abstract available.

7

Ovarian cancer genome sequencing unveils findings.

Brower V. Brower V. J Natl Cancer Inst. 2011 Sep 7;103(17):1288-90. doi: 10.1093/jnci/djr346. Epub 2011 Aug 17. J Natl Cancer Inst. 2011. PMID: 21852263 No abstract available.

8

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.

Kim SI, Lee M, Kim HS, Chung HH, Kim JW, Park NH, Song YS. Kim SI, et al. J Ovarian Res. 2019 May 7;12(1):40. doi: 10.1186/s13048-019-0511-7. J Ovarian Res. 2019. PMID: 31064392 Free PMC article.

9

Reply to D. Braun et al.

Daniels MS, Lu KH. Daniels MS, et al. J Clin Oncol. 2014 Nov 10;32(32):3683. doi: 10.1200/JCO.2014.57.6124. Epub 2014 Sep 8. J Clin Oncol. 2014. PMID: 25199758 No abstract available.

10

Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?

Vineyard MA, Daniels MS, Urbauer DL, Deavers MT, Sun CC, Boerwinkle E, Bodurka DC, Gershenson DM, Crawford J, Lu KH. Vineyard MA, et al. Gynecol Oncol. 2011 Feb;120(2):229-32. doi: 10.1016/j.ygyno.2010.10.033. Epub 2010 Dec 3. Gynecol Oncol. 2011. PMID: 21126756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

69 results

Results by year